Albireo Pharma Inc - Company Profile
Powered by 
All the sales intelligence you need on Albireo Pharma Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Albireo Pharma Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Albireo Pharma Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Albireo Pharma Lead Sheet
Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Albireo Pharma Inc’s relevant decision makers and contact details.
A sample of Albireo Pharma Lead Sheet data
| Lead Date | Lead Type | Lead Description | Company Name | Drug Name | Therapy Area |
|---|---|---|---|---|---|
| 02 Mar 2023 | GDCTWXYZ | Lorem | Lorem | Lorem | Cardiovascular |
| 02 Mar 2023 | Mergers & Acquisitions | Ipsen Acquires Albireo for Approximately USD1.15 Billion | Albireo Pharma Inc | A-2342; A-3907; A-3914; A-5425; Bile Acid Modulators; BIOD-105; BIOD-107; BIOD-123; BIOD-125; BIOD-238; BIOD-250; BIOD-530; BIOD-531; BIOD-Adjustable Basal; cholestyramine; Drug for Liver Diseases; elobixibat; glucagon; insulin glargine; insulin human; insulin lispro; Linjeta; odevixibat; Small Molecules to Agonize PPAR for IBD; teriparatide; VIAcal | Dermatology; Gastrointestinal; Genetic Disorders; Immunology; Infectious Disease; Metabolic Disorders; Musculoskeletal Disorders |
| 16 Feb 2023 | Expected Approvals/Launches | PDUFA date set on 15-Jun-2023 | Albireo Pharma Inc | odevixibat | Genetic Disorders |
| 24 Jan 2023 | Product Development - Experts | Exclusive KOL interview on expected events | Biogen Inc | - | Central Nervous System; Genetic Disorders |
Feature
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Benefit
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Value
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer